Literature DB >> 34289271

ChAdOx1 nCoV-19 Vaccine Efficacy against the B.1.351 Variant. Reply.

Shabir A Madhi1, Alane Izu1, Andrew J Pollard2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 34289271     DOI： 10.1056/NEJMc2110093

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  13 in total

1.  Virologic Features of Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Children.

Authors:  Lael M Yonker; Julie Boucau; James Regan; Manish C Choudhary; Madeleine D Burns; Nicola Young; Eva J Farkas; Jameson P Davis; Peter P Moschovis; T Bernard Kinane; Alessio Fasano; Anne M Neilan; Jonathan Z Li; Amy K Barczak
Journal:  J Infect Dis       Date:  2021-12-01       Impact factor: 7.759

2.  In-depth profiling of COVID-19 risk factors and preventive measures in healthcare workers.

Authors:  Paul R Wratil; Niklas A Schmacke; Andreas Osterman; Matthias Klein; Oliver T Keppler; Tobias Weinberger; Jochen Rech; Burak Karakoc; Mira Zeilberger; Julius Steffen; Tonina T Mueller; Patricia M Spaeth; Marcel Stern; Manuel Albanese; Hella Thun; Julia Reinbold; Benedikt Sandmeyer; Philipp Kressirer; Béatrice Grabein; Peter Falkai; Kristina Adorjan; Veit Hornung; Lars Kaderali
Journal:  Infection       Date:  2021-08-11       Impact factor: 7.455

3.  Post-Vaccination Coronavirus Disease 2019: A Case-Control Study and Genomic Analysis of 119 Breakthrough Infections in Partially Vaccinated Individuals.

Authors:  Ioannis Baltas; Florencia A T Boshier; Charlotte A Williams; Nadua Bayzid; Marius Cotic; José Afonso Guerra-Assunção; Dianne Irish-Tavares; Tanzina Haque; Jennifer Hart; Sunando Roy; Rachel Williams; Judith Breuer; Tabitha W Mahungu
Journal:  Clin Infect Dis       Date:  2022-08-25       Impact factor: 20.999

4.  Resilience of Spike-Specific Immunity Induced by COVID-19 Vaccines against SARS-CoV-2 Variants.

Authors:  Laura Ballesteros-Sanabria; Hector F Pelaez-Prestel; Alvaro Ras-Carmona; Pedro A Reche
Journal:  Biomedicines       Date:  2022-04-26

5.  Three SARS-CoV-2 antibodies provide broad and synergistic neutralization against variants of concern, including Omicron.

Authors:  Siling Wang; Hui Sun; Yali Zhang; Lunzhi Yuan; Yizhen Wang; Tianying Zhang; Shaojuan Wang; Jinlei Zhang; Hai Yu; Hualong Xiong; Zimin Tang; Liqin Liu; Yang Huang; Xiuting Chen; Tingting Li; Dong Ying; Chang Liu; Zihao Chen; Quan Yuan; Jun Zhang; Tong Cheng; Shaowei Li; Yi Guan; Qingbing Zheng; Zizheng Zheng; Ningshao Xia
Journal:  Cell Rep       Date:  2022-05-08       Impact factor: 9.995

Review 6.  COVID-19 Vaccines and the Efficacy of Currently Available Vaccines Against COVID-19 Variants.

Authors:  Suganya Panneer Selvam; Pratibha Ramani; Ramya R; Sandhya Sundar; Lakshmi T A
Journal:  Cureus       Date:  2022-05-11

7.  SARS-CoV-2 vaccines: anamnestic response in previously infected recipients.

Authors:  Jyothi N Purushotham; Neeltje van Doremalen; Vincent J Munster
Journal:  Cell Res       Date:  2021-08       Impact factor: 46.297

Review 8.  [The corona pandemic and multiple sclerosis: vaccinations and their implications for patients-Part 2: vaccine technologies].

Authors:  Tobias Monschein; Tobias Zrzavy; Micha Löbermann; Alexander Winkelmann; Thomas Berger; Paulus Rommer; Hans-Peter Hartung; Uwe K Zettl
Journal:  Nervenarzt       Date:  2021-07-07       Impact factor: 1.297

9.  Effects of common mutations in the SARS-CoV-2 Spike RBD and its ligand, the human ACE2 receptor on binding affinity and kinetics.

Authors:  Michael I Barton; Stuart A MacGowan; Mikhail A Kutuzov; Omer Dushek; Geoffrey John Barton; P Anton van der Merwe
Journal:  Elife       Date:  2021-08-26       Impact factor: 8.140

Review 10.  SARS-CoV-2 breakthrough infections in vaccinated individuals: measurement, causes and impact.

Authors:  Marc Lipsitch; Florian Krammer; Gili Regev-Yochay; Yaniv Lustig; Ran D Balicer
Journal:  Nat Rev Immunol       Date:  2021-12-07       Impact factor: 53.106
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.